Explore the Adherence of Electronic Monitoring systems in Asthma Management

<bold>Background:</bold> Asthma, characterized by chronic airway inflammation, presents intermittent symptoms and airflow restriction. Adherence to prescribed inhaler use is critical for effective management and to prevent exacerbations. The most frequent measures of adherence rely on patient-reported questionnaires or prescription refill records, neither of which are considered sufficiently reliable. Technological advancements in the development of electronic monitoring of inhaler devices allow for monitoring of use. There is limited research on inhaler adherence and its impact on asthma management. This study aimed to investigate adherence rates and their influence on asthma management using an electronic monitoring system. <bold>Methods:</bold> This prospective observational study involved adults diagnosed with asthma equipped with electronic monitoring sensors, collecting data from August 2019 to June 2020 over 90 days. <bold>Results:</bold> Thirty-nine asthma patients completed the study. Differences in adherence rates between allergy and non-allergy groups were significant at 30 days (49.9% vs. 22.8%) and 90 days (37.3% vs. 19.3%). Medication adherence rate was positively correlated with the allergic group, and negatively correlated with ICS dosage. No significant correlations were found between medication adherence rates and age, BMI, gender, or pulmonary function in both groups. <bold>Conclusion:</bold> Low medication adherence rates were noted among asthma patients, notably lower in the non-allergic group. Electronic monitoring offers insights into medication patterns, potentially enhancing asthma management strategies.